Dr. Orlando Perdomo, Director of Research and Development of CIDEM, explained to Radio Reloj, that the portfolio is divided into innovative lines, which in turn are in new entities chemicals, drugs and molecules.
He also said that they have therapeutic forms, known as super generic because they constitute an additional benefit to the conventional medicine, and pointed out that among the innovative medicines are generic products, natural products and those related to Health.
Perdomo announced that an investment was planned to increase six times the production of that institution belonging to BioCubaFarma, and have projected to build a larger one in the Special Development Zone of Mariel.
Translated by ESTI
